• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,087.15
    -304.10 (--0.55%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,149.70(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,197.50(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Megasoft Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 8034.0
  • ISIN : INE933B01012
64.15 0 (0.17%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    62.05

  • Today’s High

    66.59

  • Open

    63.68

  • Perv Close

    64.04

  • 52W Low

    49.06

  • 52W High

    111.00

Key Indicators

  • P/E(TTM)

    87.79

  • Mar.Cap (₹Cr.)

    473.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    24.03

  • Debt-Equity Ratio

    0.17

  • AGM Date

    30-Apr-2025

  • EPS

    0.75

  • P/E Ratio

    87.79

Financials Ratios

  • Debt-Equity Ratio

    0.92

  • Mar.Cap (₹Cr.)

    473.23

  • RONW (%)

    4.77

  • ROCE (%)

    7.72

Score Board

  • Equity (₹ in Cr.)

    73.77

  • BV (₹)

    24.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    7.56

  • NP Var(%)

    -27.0

  • Div%

    0.0

  • CPS (₹)

    1.50

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    485.70

  • 52 Week High

    111.00

  • 52 Week Low

    49.06

  • Price BSE

    66.0

  • Price NSE

    64.00

  • Market Capital( in Cr.)

    485.70

  • P/C Ratio

    45.30

  • P/E Ratio

    64.40

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 0.00 1.97 14.11 16.47 20.34 23.64
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 1.97 14.11 16.47 20.34 23.64
Other Income 37.35 43.82 154.25 6.86 6.50 10.14
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 37.35 45.79 168.36 23.33 26.84 33.78
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.01 0.09 0.35 0.50 0.68 0.70
Employee Cost 2.06 3.86 10.35 8.57 7.76 11.53
Other Manufacturing Expenses 0.26 1.20 2.10 1.73 1.92 3.17
Selling and Administration Expenses 6.27 12.28 4.66 3.45 5.22 5.58
Miscellaneous Expenses 0.30 3.14 139.25 1.52 3.63 7.30
Employee Benefit Expenses 2.06 3.86 10.35 8.57 7.76 11.53
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 8.90 20.58 156.71 15.78 19.21 28.28
Operating Profit 28.45 25.22 11.66 7.55 7.64 5.49
Interest 17.06 10.90 2.06 2.74 3.67 3.73
Gross Profit 11.39 14.32 9.60 4.81 3.97 1.76
Depreciation 3.19 2.84 3.39 3.43 3.45 0.98
Profit Before Tax 8.20 11.48 6.21 1.38 0.52 0.78
Current Tax 0.64 0.00 0.00 0.00 0.00 0.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.62 -0.01 -0.04 0.34
Reported Net Profit 7.56 11.48 5.58 1.39 0.56 0.41
Extraordinary Items 0.00 1.05 3.08 0.00 0.00 0.00
Adjusted Net Profit 7.56 10.43 2.50 1.39 0.56 0.41
Adjustment below Net Profit 0.00 0.03 0.00 0.00 0.00 0.00
P & L Balance brought forward 66.05 54.55 71.18 69.79 69.23 68.82
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 22.21 0.00 0.00 0.00
P & L Balance carried down 73.61 66.05 54.55 71.18 69.79 69.23
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 1.02 1.56 0.76 0.31 0.13 0.09
Earnings Per Share(Adj)-Unit Curr 1.02 1.56 0.76 0.26 0.11 0.08
Book Value 23.83 22.81 21.25 27.52 27.22 27.09
Book Value(Adj)-Unit Curr 23.83 22.81 21.25 23.20 22.94 22.83

Shareholding Pattern

  • Promoter Group

    35.07%

  • Public Share Holding

    64.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 25,873,115 35.07 25,873,115 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 25,873,115 35.07 25,873,115 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 12 0.00 12 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 99,125 0.13 99,125 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 99,137 0.13 99,137 4
2] Non Institution
Bodies Corporate 2,827,097 3.83 2,825,910 310
Clearing Members 8 0.00 8 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,313,837 4.49 3,291,776 417
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1,886,864 2.56 1,886,864 717
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 20,907,584 28.34 19,766,384 278
Individuals holding nominal share capital up to Rs. 1 lakh 18,806,520 25.49 18,482,180 32,818
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 105 0.00 105 2
Others 0 0.00 0 0
Sub Total 47,797,789 64.79 46,309,001 34,561
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 73,770,041 100.00 72,281,253 34,566

Company Background

Megasoft LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Megasoft Ltd
  • BSE Code : 8034.0
  • ISIN : INE933B01012

  • Incorporation Year

    1999

  • Registered Office

    85 Kutchery Road
    Mylapore, Chennai,
    Tamil Nadu-600004

  • Telephone

    91-44-24616768

  • FAX

    91-44-24617810

  • Chairman

  • Managing Director

  • Company Secretary

  • Auditor

    N C Rajagopal & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Megasoft Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Megasoft 65.84 37.35 0.00 87.79 7.42
Abbott India 29,876.95 6,097.18 5,848.91 47.58 44.71
Astrazeneca Phar 8,665.50 1,330.33 1,295.53 223.40 33.26
P & G Health Ltd 5,072.65 1,166.89 1,151.26 35.59 39.76
Glaxosmi. Pharma 2,959.45 3,530.73 3,407.25 58.85 44.44
Cipla 1,549.65 17,645.00 16,574.34 26.57 20.10
Amrutanjan Healt 692.80 437.58 421.23 40.61 20.84
Guj. Themis Bio. 272.65 174.19 169.82 56.45 44.82
Fermenta Biotec. 260.70 315.24 307.09 24.71 4.10
Bliss GVS Pharma 119.00 638.96 605.46 27.23 11.19
Ambalal Sarabhai 36.46 11.70 3.81 15.58 1.92